Lance Stewart is the Vice President of the BioStructures Group at deCODE genetics, Inc. (formerly Emerald BioStructures, Inc.), where he manages deCODE's protein crystallography services and products businesses. Prior to co-founding Emerald BioStructures, Inc. , he was a Postoctoral Fellow and Research Assistant Professor in the Departments of Microbiology and Biological Structure at the University of Washington. Lance Stewart has received five Small Business Innovative Research (SBIR) program grants. Lance Stewart received his Ph.D. in Biochemistry from Cornell University, his B.S.in Biology from McMaster University, and an MBA from the University of Washington.
The big revision loosely was that if we saw some crystal structures of important proteins that are drug targets with some of the known drug molecules. In this one particular case, I mentioned Taupesunrise one. At the time, it was known to be a very important anticancer drug target and I had solved...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login